European Commission logo
italiano italiano
CORDIS - Risultati della ricerca dell’UE
CORDIS
Contenuto archiviato il 2024-05-23

Praziquantel: its central role in the chemotherapy of schistosome infection

Obiettivo

This proposal will be centred on aspects of praziquantel usage and will involve a group of scientists from disease endemic countries (with a major focus on Africa). They will be linked with a group of scientists from European Member States who share their common interest in researching the clinical, biological, epidemiological , pharmacological and socio-economic aspects of praziquantel use for the control of schistosome infection and disease. The Concerted Action will provide rational answers to questions related to the use of praziquantel in order to arm national health authorities and international agencies with appropriate information to ensure implementation of effective control programmes using praziquantel . The project will provide methodological tools to deal with any outbreak of drug resistant parasites and will develop strategies that if implemented will reduce the likelihood of emergence of drug resistant parasites

Programma(i)

Argomento(i)

Data not available

Invito a presentare proposte

Data not available

Meccanismo di finanziamento

CON - Coordination of research actions

Coordinatore

UNIVERSITY OF GLASGOW
Contributo UE
Nessun dato
Indirizzo
University Avenue, Joseph Black Building
G12 8QQ GLASGOW
Regno Unito

Mostra sulla mappa
Costo totale
Nessun dato

Partecipanti (20)

Condividi questa pagina

Scarica

Ultimo aggiornamento: 12 Aprile 2005

Il mio booklet

Permalink: https://cordis.europa.eu/project/id/ICA4-CT-2002-10054/it

European Union, 2024